CAR T‐Cell Therapy in Hematologic Malignancies: A Voyage in Progress-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR T‐Cell Therapy in Hematologic Malignancies: A Voyage in Progress

Published:2019-11-25 Issue:1 Volume:107 Page:112-122
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Holstein Sarah A.¹,Lunning Matthew A.¹

Affiliation:

1. Division of Oncology and Hematology Department of Internal Medicine University of Nebraska Medical Center Omaha Nebraska USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1674

Reference109 articles.

1. Human leucocyte differentiation antigens: review of the CD nomenclature

2. Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond

3. At the Bench: Chimeric antigen receptor (CAR) T cell therapy for the treatment of B cell malignancies

4. A stepwise model of polyreactivity of the T cell antigen-receptor (TCR): its impact on the self–nonself discrimination and on related observations (receptor editing, anergy, dual receptor cells)

5. Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12

2. Mesenchymal Stem Cells Target Gastric Cancer and Deliver Epirubicin via Tunneling Nanotubes for Enhanced Chemotherapy;Current Stem Cell Research & Therapy;2024-11

3. Enhancing the activation of T cells through anti‐CD3/CD28 magnetic beads by adjusting the antibody ratio;IUBMB Life;2024-07-24

4. Adoptive T cell therapy for ovarian cancer;Gynecologic Oncology;2024-07

5. Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer;Biomedicine & Pharmacotherapy;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3